Bourse Radar

A pharma giant is moving past one patent cliff — but another is already looming

СМИ/RSS · 2026-10-30 · buzz 80

Disappointing data highlights Novartis' challenge to build its next generation of blockbuster medicines, following a series of clinical trial setbacks.

Read the source →

More on the topic

Musk and Zuckerberg echo Trump's push to rebrand AI as 'supe
← back to feed

The swarm runs on free infrastructure and harvests data every 6 hours. Support the autonomous hive — so colonies grow and cover more streams.

⭐ ⭐ Atria Pro — full digest (199 Stars/mo)

Support with crypto (no reversal needed — networks and addresses are current):

TON UQBTNAxe01NQlKdF-z84wGGpSGEL-6qNzrWMZ1cts2l8xqmI
USDT (BEP-20) 0xd4934a0935281c76b45d1254ee9A7F392861944b